Attached files

file filename
EX-32.2 - EX-32.2 - SELECTA BIOSCIENCES INCexhibit322_12312020.htm
EX-32.1 - EX-32.1 - SELECTA BIOSCIENCES INCexhibit321_12312020.htm
EX-31.2 - EX-31.2 - SELECTA BIOSCIENCES INCexhibit312_12312020.htm
EX-31.1 - EX-31.1 - SELECTA BIOSCIENCES INCexhibit311_12312020.htm
EX-4.11 - EX-4.11 - SELECTA BIOSCIENCES INCexhibit411_securitiesx1231.htm
10-K - 10-K - SELECTA BIOSCIENCES INCselb-20201231.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-8, File No. 333-212215) pertaining to the 2008 Stock Incentive Plan, as amended, the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Selecta Biosciences, Inc.,
(2)Registration Statement (Form S-8, File No. 333-224109) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan,
(3)Registration Statement (Form S-8, File No. 333-228264) pertaining to the 2018 Employment Inducement Incentive Award Plan,
(4)Registration Statement (Form S-8, File No. 333-230501) pertaining to the 2018 Employment Inducement Incentive Award Plan,
(5)Registration Statement (Form S-8, File No. 333-239075) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan,
(6)Registration Statement (Form S-3, File No. 333-236147), and
(7)Registration Statement (Form S-3, File No. 333-241692);

of our report dated March 12, 2021 with respect to the consolidated financial statements of Selecta Biosciences, Inc. included in this Annual Report (Form 10-K) of Selecta Biosciences, Inc. for the year ended December 31, 2020.

/s/ Ernst & Young LLP
Boston, Massachusetts
March 12, 2021